| mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0044 |
0.9 |
| mRNA |
lapatinib |
gCSI |
pan-cancer |
AAC |
0.0071 |
0.9 |
| mRNA |
SJ-172550 |
CTRPv2 |
pan-cancer |
AAC |
0.0049 |
0.9 |
| mRNA |
PD 153035 |
CTRPv2 |
pan-cancer |
AAC |
0.0049 |
0.9 |
| mRNA |
JQ-1:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.004 |
0.9 |
| mRNA |
BMS-754807 |
FIMM |
pan-cancer |
AAC |
0.016 |
0.9 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0042 |
0.9 |
| mRNA |
MI-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.0045 |
0.9 |
| mRNA |
BRD-K09587429 |
CTRPv2 |
pan-cancer |
AAC |
-0.0045 |
0.9 |
| mRNA |
PI-103 |
CTRPv2 |
pan-cancer |
AAC |
0.0039 |
0.9 |